Noah Rosenberg

2019

In 2019, Noah Rosenberg earned a total compensation of $1.4M as Chief Medical Officer at Retrophin, a 43% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$195,075
Option Awards$453,000
Salary$432,083
Stock Awards$215,520
Other$73,965
Total$1,369,643

Rosenberg received $453K in option awards, accounting for 33% of the total pay in 2019.

Rosenberg also received $195.1K in non-equity incentive plan, $432.1K in salary, $215.5K in stock awards and $74K in other compensation.

Rankings

In 2019, Noah Rosenberg's compensation ranked 7,785th out of 13,971 executives tracked by ExecPay. In other words, Rosenberg earned more than 44.3% of executives.

ClassificationRankingPercentile
All
7,785
out of 13,971
44th
Division
Manufacturing
3,054
out of 5,692
46th
Major group
Chemicals And Allied Products
1,150
out of 2,189
48th
Industry group
Drugs
982
out of 1,875
48th
Industry
Pharmaceutical Preparations
729
out of 1,387
47th

Pay ratio

Noah Rosenberg's Pay$1,369,643
Median Employee's Pay$266,813
Pay Ratio

5

to 1

In 2019, the annual total compensation of Noah Rosenberg was $1,369,643.

The annual total compensation of the median employee at Retrophin was $266,813.

The ratio of Noah Rosenberg's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 14, 2020.

Rosenberg's colleagues

We found six more compensation records of executives who worked with Noah Rosenberg at Retrophin in 2019.

2019

Eric Dube

Retrophin

Chief Executive Officer

2019

Peter Heerma

Retrophin

Chief Commercial Officer

2019

William Rote

Retrophin

Senior Vice President and Head of Research and Development

2019

Laura Clague

Retrophin

Chief Financial Officer

2019

Elizabeth Reed

Retrophin

General Counsel

2019

Stephen Aselage

Retrophin

Chief Executive Officer

News

You may also like